Estrella Immunopharma- Warrants (29/09/2028) Net Tangible Assets

As of the most recent data (June 2026), ESLAW shows a net tangible assets of $-7.4M. That compares with $-6.1M in the prior-year period — down 21.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ESLAW's net tangible assets is now $-7.4M (was $-6.1M) — a 21.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Estrella Immunopharma- Warrants (29/09/2028) is outperforming or lagging.

Tracking ESLAW's net tangible assets over time shows whether Estrella Immunopharma- Warrants (29/09/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $-7.4M That compares with $-6.1M in the prior-year period — down 21.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Estrella Immunopharma- Warrants (29/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-7.4M) with ownership activity and broader fundamentals.